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Abstract The properties of meshes used in reconstructive sur-
gery affect the host response and biomechanical characteristics of
the grafted tissue. Whereas durable synthetics induce a chronic
inflammation, biological grafts are usually considered as more
biocompatible. The location of implantation is another determi-
nant of the host response: the vagina is a different environment
with specific function and anatomy. Herein, we evaluated a
cross-linked acellular collagen matrix (ACM), pretreated by the
anti-calcification procedure ADAPT® in a sheep model for
vaginal surgery. Ten sheep were implanted with a cross-linked
ACM, and six controls were implanted with a polypropylene
(PP; 56 g/m2) control. One implant was inserted in the lower
rectovaginal septum, and onewas used for abdominal wall defect
reconstruction. Grafts were removed after 180 days; all graft-
related complications were recorded, and explants underwent
bi-axial tensiometry and contractility testing. Half of ACM-
implanted animals had palpable induration in the vaginal implan-
tation area, two of these also on the abdominal implant. One
animal had a vaginal exposure. Vaginal ACMs were 63 % less
stiff compared to abdominal ACM explants (p=0.01) but com-
parable to vaginal PP explants. Seven anterior vaginal ACM
explants showed areas of graft degradation on histology. There
was no overall difference in vaginal contractility. Considering
histologic degradation in the anterior vaginal implant as repre-
sentative for the host, posterior ACM explants of animals with
degradation had a 60 % reduced contractility as compared to PP
(p=0.048). Three abdominal implants showed histologic
degradation; those were more compliant than non-
degraded implants. Vaginal implantation with ACM was
associated with graft-related complications (GRCs) and
biomechanical properties comparable to PP. Partially degraded
ACM had a decreased vaginal contractility.
Keywords Graft-related complication . Biological graft .
Prolapse . Biomechanics . Contractility
Introduction
Pelvic organ prolapse (POP) develops in half of parous women
over 50 years, half of them being symptomatic with only 20 %
of them seeking medical help [1, 2]. Lifetime risk of POP
surgery is 19 % [3], and up to 25 % require later re-operation
[4]. It was suggested that this may be reduced by using synthetic
or biological implants [4, 5]. Although durable synthetic meshes
are known to achieve good anatomical and functional results for
cystocele repair, they may cause graft-related complications
(GRCs) in over 10 % of women [4]. Alternative grafts that
may reduce the number of GRC yet still provide durable results
could be contemplated [6–10].
Biological grafts are derived from either human (autograft
or allografts) or animal material (xenografts). Autografts, such
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as fascia lata, inherently have donor site-related morbidity and
also have unpredictable durability [11, 12]. Allografts are
retrieved from cadaveric tissue, and although fastidious steps
are taken in preparation, concerns regarding transmission of
possible prion disease or viruses remained. Xenografts are
acellular collagen matrices (ACMs) that are either derived
from the dermis, pericardium or small intestinal submucosa
of animals that are purposely bred in strictly controlled
conditions. Most ACMs are of bovine or porcine origin,
which, during their production, undergo various chemical
procedures (cross-linking, sterilization). After implantation,
ACMs are remodelled and/or replaced by connective tissue
within variable time periods. The latter can be modified using,
e.g. cross-linking agents which leads to the formation of
excessive intramolecular and intermolecular chemical bonds
preventing decomposition by endogenous collagenases [13].
This alters the properties of the ACM either physically or
chemically. A commonly used cross-linking agent is
glutaraldehyde (GAD) [13] resulting in durable grafts that
are slowly integrated and remodelled. However, residual
GAD is cytotoxic andmay cause calcification. To prevent this,
Neethling et al. developed a multi-step anti-mineralization
process called ADAPT® [14]. This enhances crosslink
stability, removes residual GAD and modifies the non-
bifunctionally reacted GAD residues. The process reduces lipid
content and restores tissue elasticity [14]. ADAPT®-treated
bovine pericardial patches have been successfully used in
surgery of congenital heart defects without demonstrable
calcification in a 36-month follow-up period [15]. These
promising results demonstrating long-term stability in
challenging circumstances are worthwhile considering for
translation in pelvic floor surgery. Herein, we used
ADAPT®-treated xenografts in a sheep model for
transvaginal surgery, studying both the occurrence of GRCs
and active and passive biomechanical properties of the vaginal
wall. As a reference, we compared outcomes to repairs with
light weight polypropylene (PP) implants.
Materials and methods
Implants and surgery
This study compares outcomes following vaginal and abdominal
mesh insertion of either a xenogenic or synthetic implant in a
sheepmodel. The xenogenic graft was a non-perforated acellular
collagen matrix (ACM) derived from bovine pericardium which
was cross-linked with an ultra-low concentration (0.05 %) of
monomeric GAD. Further preimplantation processing included
the so-called ADAPT® anti-calcification procedure and sterili-
zation with propylene oxide [14, 16] (material donated by Prof
WML Neethling, Fremantle, Australia). As a control, we used a
commercially available monofilament polypropylene (PP) mesh
used for vaginal prolapse repair (PP) (Avaulta Solo; 56 g/m2,
Bard Medical, Covington, GA, USA). The latter was purchased
and delivered sterile via the hospital pharmacy. Observations of
these animals were earlier reported on elsewhere [17].
The anaesthetic, surgical technique and methodology used
for outcome evaluation have been described in detail previously
[18, 19]. Briefly, 16 parous Texel sheep (mean weight 68±
3.5 kg) were obtained from the Zootechnical Centre of the KU
Leuven. They underwent simultaneous vaginal and abdominal
implantation with either ACM (N=10) or PP (N=6). Surgery
was conducted in sterile conditions under general anaesthesia
with prophylactic antibiotics at induction and 3 days of
postoperative analgesia. Following aqua dissection, a single
incision was made in the recto-vaginal septum that was then
dissected to create a suitable space for a 35×35 mm suture
fixed prosthesis (posterior implant) (Fig. 1). Additionally, a
10×20 mm graft was inserted in the anterior vaginal wall
(anterior implant). Finally, a 50 mm longitudinal paramedian
cutaneous incision was made in the anterior abdominal wall,
and a 40-mm primarily suture repaired full-thickness fascial
incision was overlaid with the same graft as used vaginally
(Fig. 1). All implants were fixed with interrupted PP 4/0
prolene sutures (Ethicon). Postoperatively, animals were
allowed to move, drink and eat ad libitum and were clinically
followed by a veterinarian.
Outcome measures
On average, 180 days later, animals were euthanized, and during
necropsy graft-related complications (GRCs) or the presence of
herniation was noted at each of the three implantation sites.
Thereafter, the original implant together with the adjacent and
ingrown tissue (further referred to as explant) was removed Ben
bloc^ and its dimensions and thickness were determined as an
average of three random measurements with a digital
micrometer (Mitutoyo, Kawasaki, Japan; accuracy 0.01 mm).
Contraction of the explant was defined as the explant area
over initial graft area (1225 mm2 for vaginal, 2500 mm2 for
abdominal implant, respectively). Explants were then divided
to obtain specimens for histology and biomechanical testing as
shown in Fig. 1. For vaginal explants, the anterior specimens
were used for histology while the posterior explants were used
for active and passive biomechanical testing. The larger
abdominal explants were divided for both histology and
passive biomechanics.
Histology quantified the inflammatory response and
connective tissue formation on 5-μm-thick sections,
stained with hematoxylin and eosin (H & E) and Movat
pentachrome, using an ordinal scoring system [20, 21].
Two operators blinded to the initial treatment counted foreign
body giant cell (FBGC), polymorphonuclear (PMN) cells,
newly formed vessels and collagen organization, composition
and amount in five randomly chosen areas at the implant–host
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tissue interface at a magnification×400 (Zeiss Axioplan 400,
Oberkochen, Germany). Infection was classified as either low
grade (≥15 PMN per HPF and no clinical evidence of infection)
or high grade (presence of micro-abscesses, dense
inflammatory infiltrate, fibrin exudation, bleeding and
necrosis as well as clinical signs of infection, if any) [22]. All
histological scores (FBGCs, PMN, vessel and collagen scores)
were at least done in duplicate and averaged.
Passive biomechanics were tested using bi-axial tensiometry
by a plunger test on a 500-N Zwick tensiometer with a 200-N
cell load (Zwick GmbH & Co. KG, Ulm, Germany) using
a protocol defined earlier [18]. A spherical 11.5 mm plunger
was passed through an aperture ∅20 mm that exposing the
explant compressed in∅30-mm rings. All explants were placed
with the graft facing upward. Records of the force–elongation
relationship allowed to define the stiffness (N/mm) of the tested
material, which we measured in the low-stress area also called
as the Bcomfort^ zone, the average slope of the force–
elongation curve and the length of the former zone. These
values were determined by TestXpert II software (Zwick
GmbH & Co). Active biomechanics of a circumferential-
oriented posterior vaginal explant as well as control strip
(10×8 mm) were assessed by a contractility assay (Fig. 1)
[23]. This is an ex vivo assessment quantifying the ability of
the smooth muscles present in vaginal tissue strips to contract
by immersing them in an organ bath at 80 mM KCl concen-
tration (mN/mm3), suggested as a proxy for vaginal function.
Statistical analysis and ethics committee approval
Data are reported as mean and standard deviation or as median
and interquartile range depending on the distribution. Either
a Student’s t test or a Mann–Whitney U test was performed to
compare PP and ACM. Chi-square was used for categorical
data. Pairs of abdominal and vaginal explants from the same
animal were also tested using a paired t test or Wilcoxon
signed-rank test. All analyses were performed with Prism 5
(GraphPad Software, Inc., La Jolla, CA, USA), and the sig-
nificance level was set up to p<0.05. Animals were housed in
controlled conditions and treated in accordance with current
national guidelines on animal welfare. The experiment was
approved by the Ethics Committee for Animal Experimenta-
tion of the Faculty of Medicine of the KU Leuven.
Results
Vaginal versus abdominal implantation of ACM
Five out of ten sheep implanted with ACM developed GRCs
at the vaginal implantation site (50 %; Table 1). There was one
exposure, two implants showed clinically obvious folding
(Fig. 2), and two showed remarkable induration. The total
GRC rate for xenogenic implants in the abdominal wall was
30 %. Animals that had induration in their vaginal implants
also showed induration of their abdominal implants.
In one vaginal explant, there was macroscopically no
visible implant in between the fixation sutures any more.
Vaginal and abdominal explants were of comparable thick-
ness, though the contraction rate was almost three times higher
in vaginal explants (p=0.0008). There were significant
differences between implantation sites for passive biomechanics:
vaginal explants were 63 % less stiff than their abdominal
counterparts (p=0.01), though the length of the comfort zone
was comparable (Fig. 3a). Explants were also categorized by
histologic signs of degradation. In the presence of histologic loss
of implant integrity, degraded abdominal implants were more
compliant than those without degradation (0.44 vs. 0.79
N/mm). Because of the low number, no statistics were done.
For vaginal implants, the histology was taken from the anterior
side. Of those animals with histologic signs of degradation, their
corresponding posterior implants were compared to those with-
out degradation. The compliance of posterior implants of animals
with degradation in the anterior implant was lower than in those
without (0.33 vs. 0.15 N/mm). Again, no statistics were done.
Histology of vaginal explants was scored on smaller ante-
rior vaginal implants (Table 2). Onemust remember that this is
a different location than the rectovaginal area described above.
ACM abdominal explants had higher scores for FBGC
(p=0.0078) yet similar amounts of PMN and vascularization
Fig. 1 Schematic drawing of
abdominal (a) and vaginal (b)
implantation in the sheep model.
Specimens explanted (c) from the
abdomen and anterior (ant) and
posterior (post) vaginal wall were
divided according with their
respective testing method. The
arrow is pointing cranially in the
direction to the uterine cervix
(illustration by Myrthe Boymans)
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as vaginal ACM explants. Scores for collagen organization
and composition were similar for both sites, but the amount
of collagen was higher in the abdominal ACM explants
(p=0.0201). All the above scores were averages. At closer look,
explants fall apart in two categories. In 70 % of the anterior
vaginal and 30 % of the abdominal explants, we could not trace
the typically dense structure of the ACM on histology (Fig. 2d,
e). In these cases, there was no measurable inflammation but
limited areas of organized andmature connective tissue. Isolated
pockets of inflammation were visible only when a suture was
accidentally caught in the section. In the other cases, the ACM
could be identified. In that case, there was an abundance of
inflammatory cells, both FBGC and PMN, as evidenced by their
score, as well as connective tissue deposition. In five ACM
sections, we observed a precipitated material compatible with
calcification (Fig. 2c). Four were abdominal explants; three of
themwere macroscopically categorized as indurated. In one of
these ewes, also the anterior and posterior vaginal explants
were indurated. The anterior explant showed calcification on
histology, which coincided with histologic signs of infection).
Vaginal contractility and comparison to PP vaginal implants
Figure 3 displays the vaginal contractility findings. Posterior
ACM explants where no graft was recognizable on histology
(n=7) and the corresponding anterior vaginal implant had
a 68 % lower contractility than those with recognizable
material (n=3; Fig. 3b). Again, in view of the very low
numbers, no statistics were attempted.
We compared the vaginal contractility and other findings to
observations made earlier when using a PP vaginal implant
(Table 3). In the PP group, there was one case of GRC
(folding), yet this apparently lower number was not signifi-
cant. However, the 17 % contraction rate of PP explants was
significantly less than for ACM (p=0.0009). Passive biome-
chanics of all vaginal ACM were comparable to observations
in the PP explants. Compliance of degraded ACM (0.33
N/mm) was within the range of what was measured in PP
(0.29 N/mm) explants. Active biomechanical findings were
also comparable. However, the values of three animals with
recognizable ACM were in the range of the PP-implanted
animals. Conversely, the forces generated by the seven ani-
mals without degradation in the anterior ACM were 60 %
lower than those of PP explants (p=0.048) (Fig. 3b).
The histology of vaginal explants with PP differed
completely from those with recognizable ACM (Fig. 2f).
PP induced a mild inflammation, with few cells, nearly all
macrophages or FBGC, and less collagen deposition. These
specimens showed no histologic signs of infection.
Discussion
In this study, we used the ovine model to document outcomes
following insertion of a cross-linked ACM in the rectovaginal
septum and, for histology, insertion of a smaller piece into
the anterior vaginal wall. We used an investigational product
that was treated with the ADAPT® procedure to prevent cal-
cification, reduce lipid content and restore tissue flexibility.
We used a double control, i.e. an internal control by implan-
tation of the same material at a control site (the abdominal
wall) and an external control by implantation of a durable
PP implant at the same (vaginal) site.
Table 1 Paired comparison of
outcomes of vaginally and
abdominally implanted ACMs
Biomechanical findings are
displayed for all animals as well
as results without the outlier, and
contraction is displayed without




Graft-related complication 3/10 (30 %) 5/10 (50 %) ns
Exposure 0/10 (0 %) 1/10 (10 %)
Folding 0/10 (0 %) 2/10 (20 %)
Induration 3/10 (30 %) 2/10 (20 %)
Other gross anatomical findings
Thickness (mm) 8.22±3.90 6.78±2.27 ns
Material not identifiable 0/10 (0 %) 1/10 (10 %) ns
Contraction of identifiable mesh −20.28 %±18.24 −61.18 %±17.25 0.0008
Biomechanics
All ewes
Comfort zone stiffness (N/mm) 0.68±0.2 0.41±0.46 ns
Comfort zone length (mm) 7.18±2.00 8.52±3.22 ns
Exclusion of outlier (n=9)
Comfort zone stiffness (N/mm) (n=9) 0.73±0.29 0.27±0.19 0.0101
Comfort zone length (mm) (n=9) 7.30±2.00 8.90±3.17 ns
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Conceptually, ACM is the ideal matrix for gradual integra-
tion into the host. In order to avoid adverse reactions, ACMs
are made free of allergens, DNA and other pathogens. Cross-
linking shouldmake them resistant to endogenous collagenase
activity. However, several experimental and clinical studies
report unfavourable outcomes with the use of a variety of
ACM. Clinically, both GRC and failure were reported
[24–27]. Also, our experiment revealed a number of GRC.
The first striking observation was the presence of calcification
on histology. This happened at both anatomical locations and
not in the control group. Calcification of GA cross-linked
grafts has been tied to residual non-viable cells and cellular
Fig. 2 Gross anatomy. Explants from the posterior vaginal wall (a) and
the abdomen (b) with induration and folding visible in the below placed
selections. The dark area (arrows) below the vaginal epithelium and
above the abdominal muscles is the location of the implant, which
looks complete. In these cases, the material was hard on palpation and
surrounded with excessive amount of connective tissue. Histology
showed variable host response (c–e), gradual degradation of ACM with
mineral precipitation or calcification (asterisk; c) and FBGC (arrow) on
the graft–tissue interface (d), or complete ACM degradation where just
sutures (S) were identifiable (e). Polypropylene implant (PP) showed
uniform response (f). (H & E, ×40, ×200, ×25, ×100, respectively)
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debris that were not removed during GAD pretreatment. They
serve as nucleation sites for calcium phosphate minerals.
GAD modifies phosphorous-rich cell membranes that are
capable of mineralization using calcium present in the extra-
cellular fluid [28, 29]. This adverse effect was meant to be
prevented by the ADAPT® procedure, which has been earlier
shown to work in previous experimental studies in rats and
sheep [30–32]. Clinical studies on the use of the samematerial
for cardiac defects showed minimal or no mineral precipita-
tion in the matrices [15]. This was reassuring because
pathological calcification is a feared complication in cardiac
surgery, certainly in young patients [33, 34]. Another identi-
fied risk factor for calcification of grafts is the occurrence of
infection or folding [35, 36]. These may add to other surgical
factors, such as haemorrhage, or damage by surgical handling.
To our knowledge, no previous studies have looked at the use
of this material for surgical repair of the abdominal wall
or a vaginal environment.
Themost common local observation was palpable induration
at the implant site. Histologically, this did not always coincide
with calcification but may also with contraction, folding and
wrinkling. There are no published data on contraction rates fol-
lowing insertion of cross-linked ACM in the vagina. Studies on
abdominal insertion showed various results. Ozog et al. reported
minimal or unchanged dimensions in 180 days with Pelvicol in
rats, however, without visible deformation [37]. Conversely,
Jenkins et al. reported a 50 % area reduction and wrinkling for
abdominal wall reconstruction after 3 months in mini pigs using
Collamend (another cross-linked porcine dermis; Bard,
Davol, RI) [38]. They explained the process by the presence
of encapsulation, though we observed that process also in
non-contracted ACM [37]. Contraction is, however, not the
privilege of ACM, as significant contraction rates have been
reported following PP implantation both in the vagina
(45 %) and abdomen (10 %) 90 days after surgery [18].
We also observed various stages of graft degradation in
30 % of abdominal and 70 % of vaginal explants. The occur-
rence of degradation of cross-linked ACM has been reported
by several groups in different models [39–42]. Claerhout et al.
documented degradation in rabbit abdominal Pelvicol (Bard,
Haasrode, Belgium) implants from 180 days onwards [40],
and Pierce documented the same for vaginal Pelvisoft
implants [41]. In a clinical study, we saw the same when
Pelvicol was used for laparoscopic sacrocolpopexy, leading
to recurrence [24]. Graft degradation coincided in 8 out of 9
cases with an abundance of foreign body (giant) cells on bi-
opsy [43]. Description of the exact time course of degradation
is currently impossible since clinical, as experimental studies
usually involve only one time point. Interestingly, degradation
does not occur in the same way at both locations. Pierce et al.
showed more degradation of Pelvisoft (Bard, Covington, GA)
270 days following vaginal than abdominal implantation [44].
The same difference was present in our study. It is not possible
to determine whether this is a faster or more vigorous process.
However, Abramov et al. showed differences between
the wound healing response in the vagina and in the abdomen,
which may lead to another remodelling process [45].
Vaginal ACM explants were around 2.7 times less stiff than
their abdominal counterparts. To our knowledge, there are no
studies on biomechanics following simultaneous ACM
implantation in both locations, so we do not have references
to compare to. However, differences in biomechanics for these
two environments were studied following insertion of PP
(Gynemesh; Ethicon, Somerville, NJ) in a rabbit [44]. Vaginal
explants were 1.5 less stiff than abdominal explants. Both
observations follow a trend reported on biomechanics of
cadaverous native tissue from the vagina and abdominal
aponeurosis [46]. Gabriel et al. reported the vaginal wall being
four times less stiff than abdominal aponeurosis. There are, to
our knowledge, no published reference data on the biomechanics
of native vaginal tissue and abdominal wall.
Graft degradation is another factor of relevance, as it interferes
with the biomechanical properties. For that reason, we compared
stiffness of those animals where no ACM was visible anymore
versus those where the material was conserved. Effects seemed
to be different according to the location of implantation. Yet,
Fig. 3 Box plots and individual data of passive (a) and active (b) biomechanical tests. Individual data are plotted (black circle) with median and
interquartile range marked with gray lines. The not identifiable implant is marked with an empty circle and outlier red circle
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low numbers preclude actual statistical assessment, and more
importantly, degradation was determined on the anterior
implant, whereas biomechanics on the posterior implant.
For those reasons, we prefer not to make any firm conclusions
on this matter.
Smooth muscle contractility showed, at the first glance, no
difference for the explants using different implant materials.
Further analysis into two subgroups revealed a 68 % decline
of forces in group without visible ACM. When there was still
detectable ACM, findings were comparable to PP-implanted
tissues. In other words, the absence of material coincides with
reduction in contractility. In line with other studies, we further
demonstrated that ACM implants affect smooth muscle con-
tractility [47]. This is somewhat counter-intuitive unless one
assumes that earlier in time, the implant may have already
compromised contractility, e.g. by a process of stress
shielding, as described by others [47–49]. To elucidate that,
one would, however, need a study with several time points and
appropriate native tissue controls, and the mechanisms remain
therefore unexplained.
Table 2 Histological scores of host response and connective tissue formation following insertion of ACM and PP in the vagina and abdominal wall
Histology Abdomen Anterior vagina Pair comparison Anterior vagina Unpaired comparison
ACM PP
N=10 N=10 N=6
FBGC 0.8 (0.88) 0.1 (0.53) 0.0078 0.40 (0.25)
PMN 0.15 (0.38) 0.2 (0.67) 0.05 (0.23)
Vascularity 1.0 (0.4) 1.15 (0.3) 2.05 (0.55) 0.0023
Collagen organization 1.5 (1.4) 1.4 (0.35) 1.3 (0.55)
Collagen composition 1.8 (0.4) 2.1 (0.4) 2.3 (0.55)
Collagen amount 2.7 (0.2) 2.5 (0.2) 0.0201 1.9 (0.35) 0.0061
Calcification 4/10 1/10 0/6
Scores at the interface with identifiable
material on histology
N=7 N=3 N=6
FBGC 1.1 (0.7) 0.8 (0.35) 0.40 (0.25)
PMN 0.1 (0.45) 1.8 (0.85) 0.05 (0.23)
Vascularity 0.7 (0.45) 1.5 (0.45) 2.05 (0.55)
Collagen organization 1.4 (1.0) 0.8 (0.5) 1.3 (0.55)
Collagen composition 1.8 (0.3) 2.4 (0.3) 2.3 (0.55)
Collagen amount 2.8 (0.3) 2.8 (0.1) 1.9 (0.35)
Scores are displayed for all explanted specimens and also for those with identifiable ACM. For later, statistics was not carried out due to a few specimens.
Data for vaginal PP implants were previously published by Feola et al. 2014 [17]
FBGC foreign body giant cell, PMN polymorphonuclears
Table 3 Outcomes and test results of vaginally implanted ACM and PP and their unpaired comparison (significance level p<0.05)
ACM PP Unpaired comparison
Posterior vagina Posterior vagina
N=10 N=6
Graft-related complication 5/10 (50 %) 1/6 (16.6 %) 0.0367
Exposure 1/10 (10 %) 0/6 (0 %)
Folding 2/10 (20 %) 1/6 (16.6 %)
Induration 2/10 (20 %) 0/6 (0 %)
Contraction of identifiable mesh −53.82 %±10.20 (n=7) −23.06 %±16.63 0.0009
Biomechanics
Comfort zone stiffness (N/mm) 0.27±0.19 (n=9) 0.29±0.12 ns
Comfort zone length (mm) 8.89±3.17 (n=9) 8.18±1.67 ns
Contractility (mN/mm3) 0.017±0.015 (n=10) 0.025±0.016 ns
Degraded (n=7) 0.010±0.007 0.025±0.016 0.0481
Non-degraded (n=3) 0.031±0.019 – –
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Our study has several limitations. Again, we only studied
one time point, precluding insight into the time course of
the host response; hence, it cannot learn on the processes
driving the adverse events neither. Another is the use of a
semiquantitative histological scoring system and limited stain-
ing methods. Though they are descriptive, it would be much
more informative to also have biochemical andmolecular read
outs to document details on the nature of the immune
response, neovascularization, collagen metabolism and nerve
ingrowth [50]. This might be difficult to do, as those tools are
not readily available in sheep and also add significantly to the
cost. Further, we had to resort to use a second vaginal location
for implantation so that we could obtain sufficient tissue for
histology, without compromising the availability of tissue for
biomechanical testing. Further, there are the limitations of
the model; even though sheep can be used as a model for
vaginal surgery as well as prolapse [18], it remains mostly an
asymptomatic quadruped, with clinically different anatomical
and pelvic floor loads, hence not an ideal disease model. It has
however several advantages: apparently, sheep may clinically
develop obvious pelvic floor relaxation and some degree of
prolapse after delivery; further, this is a widely available,
affordable alternative to the primate, which would be the closest
model that we could think off.
In conclusion, we demonstrated that despite treatment with
ADAPT®, ACM insertion into the rectovaginal septum was
associated with a number of local adverse effects. Apart from
that, the passive biomechanical properties were not better than
what was obtained when a PP mesh was used. Following
degradation of the ACM, there was a decrease in smooth
muscle contractility. The ideal implant material has apparently
not yet been identified.
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